BRCA1 and metastatic colorectal cancer: In summary, our case presented a rare case of metastatic colorectal cancer as the primary phenotype of BRCA1 associated HBOC and benefited from PARP (poly (ADP-ribose) polymerase) inhibitor of olaparib.